Akome Biotech

Akome Biotech is a Spanish biotechnology company focused on the development of new therapies for neurodegenerative and inflammatory diseases. The company utilizes a proprietary platform to identify and optimize synergistic combinations of natural compounds, particularly those targeting neuro-regeneration and neuro-inflammation. Their current pipeline includes programs for Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis. By focusing on multi-target approaches, Akome aims to address the complex pathology of central nervous system disorders more effectively than traditional single-target drugs. The company is headquartered in Madrid and maintains strong ties with leading research institutions to advance its pre-clinical candidates.